Sector News

A. Schulman to buy specialty plastics maker for $800 mln

March 16, 2015
Chemical Value Chain
(Reuters) – Specialty chemical maker A. Schulman Inc said it would buy privately held Citadel Plastics Holdings Inc for $800 million to expand its specialty business that makes moldable plastics.
 
Citadel Plastics, owned by private equity firms HGGC and Charlesbank Capital Partners, makes thermoplastic polymers and thermoset plastics.
 
Thermoplastics, which melt when heated and then set to a solid state when cooled, are used in cookware, medical devices, toys and plastic bottles. Thermoset plastics can only be heated and shaped once and are used in electric insulators and fittings, adhesives and laminates.
 
Citadel operates 21 factories across the world, including 10 thermoplastic factories and seven thermoset factories in the United States and Canada.
 
“Their product offering … presents attractive expansion opportunities in other fast-growing sectors such as aerospace, medical, LED lighting and oil & gas,” A. Schulman Chief Executive Bernard Rzepka said in a statement.
 
A. Schulman, which sells products used in the electronics and construction industries, among others, expects the deal to add to its earnings in the first 12 months of ownership.
 
The deal is expected to close in the third quarter of 2015.
 
HSBC Securities (USA) Inc acted as financial adviser to A. Schulman and Squire Patton Boggs LLP was its legal counsel. (Reporting by Anannya Pramanick and Sneha Banerjee in Bengaluru; Editing by Savio D’Souza and Maju Samuel)

Related News

February 28, 2021

Borealis to invest in new RTO to reduce CO2 emissions at Porvoo polyolefins plant

Chemical Value Chain

This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.

February 28, 2021

Grace to acquire Albemarle’s fine chemistry business for $570 million

Chemical Value Chain

The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.

February 28, 2021

Solvay to carve out soda ash business

Chemical Value Chain

Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.

Send this to a friend